vTv Therapeutics Inc. Class A Common Stock

VTVT Real Time Price USD

N/A

...

Trade VTVT

...

Overview

Financials

Insiders

Institutions

Government

Income

Balance Sheet

Cash Flow

VTVT Income Statement

VTVT Balance Sheet

VTVT Cash Flow

Congress Trading

Recent trades of VTVT by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

VTVT Stock Insider Trading Activity

Name	Type	Shares	Price	Shares Held	Date	Reported

VTVT Stock Institutional Owners

Investor	Shares	Change in Shares	Market Value	Date	Reported

VTVT Derivatives Institutional Owners

Investor	Type	Shares	Change in Shares	Market Value	Date	Reported

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by VTVT's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Corporate Lobbying

Estimated quarterly lobbying spending

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

Patent Title: Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof Sep. 17, 2024
Patent Title: Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs May. 07, 2024
Patent Title: Metabolites of [3-(4-(2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h-imidazol-4-yl)-phenoxy)-propyl]-diethyl-amine Apr. 30, 2024
Patent Title: Pharmaceutically acceptable salts of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine Jan. 30, 2024
Patent Title: Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs Dec. 05, 2023
Patent Title: Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof May. 16, 2023
Patent Title: Metabolites of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h-imidazol-4 yl}-phenoxy)-propyl]-diethyl-amine Dec. 13, 2022
Patent Title: Crystalline forms of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine Aug. 23, 2022
Patent Title: Phenoxy acetic acids and phenyl propionic acids as ppar delta agonists Aug. 23, 2022
Patent Title: Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof Sep. 28, 2021
Patent Title: Use of a ppar-δ agonist for reducing loss of muscle strength, muscle mass, or type i muscle fibers in an immobilized limb Aug. 24, 2021
Patent Title: Glucokinase activator compositions for the treatment of diabetes Apr. 20, 2021
Patent Title: Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs Mar. 23, 2021
Patent Title: Phenoxy acetic acids and phenyl propionic acids as ppar delta agonists Mar. 16, 2021
Patent Title: Bach1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof Jan. 26, 2021
Patent Title: Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof Jan. 12, 2021
Patent Title: Glucokinase activator compositions for the treatment of diabetes Mar. 17, 2020
Patent Title: Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof Feb. 25, 2020
Patent Title: Tricyclic compounds as modulators of tnf-alpha synthesis and as pde4 inhibitors Feb. 25, 2020
Patent Title: Phenoxy acetic acids and phenyl propionic acids as ppar delta agonists Nov. 12, 2019
Patent Title: Bach1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof Nov. 05, 2019
Patent Title: Use of a ppar-δ agonist for reducing loss of muscle strength, muscle mass, or type i muscle fibers in an immobilized limb Oct. 29, 2019
Patent Title: Tricyclic compounds as modulators of tnf-alpha synthesis and as pde4 inhibitors Aug. 27, 2019
Patent Title: Piperidine derivative and methods of use thereof Jul. 30, 2019
Patent Title: Compositions comprising metformin and a glucokinase activator Jul. 30, 2019
Patent Title: Substituted imidazole derivatives and methods of use thereof Jul. 30, 2019
Patent Title: Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof May. 14, 2019
Patent Title: Bach1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof Jan. 08, 2019
Patent Title: Tricyclic compounds as modulators of tnf-α synthesis and as pde4 inhibitors Oct. 02, 2018
Patent Title: Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator Sep. 04, 2018
Patent Title: Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof Jul. 24, 2018
Patent Title: Glucokinase activator compositions for the treatment of diabetes Jun. 26, 2018
Patent Title: Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type i muscle fibers in an immobilized limb May. 15, 2018
Patent Title: Phenoxy acetic acids and phenyl propionic acids as ppar delta agonists Jan. 02, 2018
Patent Title: Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator Jan. 02, 2018
Patent Title: Tricyclic compounds as modulators of tnf-α synthesis and as pde4 inhibitors Dec. 05, 2017
Patent Title: Treatment of mild and moderate alzheimer's disease Aug. 01, 2017
Patent Title: Compounds that modulate oxidative stress Jul. 18, 2017
Patent Title: Tricyclic compounds as modulators of tnf-α synthesis and as pde4 inhibitors Jun. 27, 2017
Patent Title: Phenoxy acetic acids and phenyl propionic acids as pparδ agonists May. 30, 2017
Patent Title: Substituted imidazole derivatives and methods of use thereof Mar. 21, 2017
Patent Title: Use of a ppar-delta agonist for treating muscle atrophy Nov. 08, 2016
Patent Title: Compounds that modulate oxidative stress Sep. 20, 2016
Patent Title: Tricyclic compounds as modulators of tnf-alpha synthesis and as pde4 inhibitors Jul. 19, 2016
Patent Title: Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator Jun. 07, 2016
Patent Title: Tris(hydroxymethyl)aminomethane salts of a small-molecule glp1r agonist and pharmaceutical compositions and uses thereof Dec. 01, 2015
Patent Title: Substituted azoanthracene derivatives and intermediates for preparation thereof Nov. 03, 2015
Patent Title: Tricyclic compounds as modulators of tnf-α synthesis and as pde4 inhibitors Oct. 20, 2015
Patent Title: Phenylglyoxylic acid derivatives and their preparation and use Oct. 20, 2015
Patent Title: Oxadiazoanthracene compounds for the treatment of diabetes Sep. 01, 2015

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Government Contracts

Estimated quarterly amount awarded from public contracts

No recent Government Contracts for this ticker

Government Contracts Dashboard

WallStreetBets

Number of mentions of VTVT in WallStreetBets Daily Discussion

VTVT News

Recent insights relating to VTVT

CNBC Recommendations

Recent picks made for VTVT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in VTVT

VTVT Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.

Score Breakdown

Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.